top of page

CT

C

December 9 - 11, 2024
The Mayflower Hotel, Washington DC

Global CVCT Forum

CVCT 2023 multistakeholders

CROs-AROs

Academics

Principal Investigators

Patients-

Advocacy

Regulatory

(FDA, EMA)

Industry R&D

Clinicians

Lawyers

Major journal editors

Statisticians-Methodologists

Payers-HTAs

MedTech-BioTech

Investors

CVCT Chairpersons

Faiez Zannad, Founder and Chairman of CVCT

Faiez Zannad

Founder & chairman

UNIVERSITE DE LORRAINE, NANCY, FRA

Bertram Pitt

Co-chairman

UNIVERSITY OF MICHIGAN, ANN ARBOR, USA

Bertram Pitt, CVCT

Scientific Program Advisors

ULTIMATE DEEP DIVE IN MAJOR RECENT CLINICAL TRIALS

1/11

NEW AT CVCT 2024 : GOING GLOBAL

EXPANDING THE REACH OF THE FORUM TO INCLUDE UNDER-REPRESENTED “MOW” (MOST OF THE WORLD) TRIALISTS, FROM LATAM, AFRICA-ME, AND ASIA-PACIFIC IS CRUCIAL FOR FOSTERING DIVERSITY.

Beyond the occasional regional past CVCT meetings (CVCT Asia, and CVCT MEMA), this year, more work will be put into involving faculty members and regulators from these global regions.

1/6

CLINICAL TRIAL SCIENCE
AT ITS BEST

EXPAND OVER

INCLUDING

INVOLVING

03

40

400

DAYS

SESSIONS

SPEAKERS

THE LARGEST GLOBAL GATHERING OF CLINICAL TRIALS KEY STAKEHOLDERS!

1/12

BEYOND CARDIOLOGY, CVCT

AT THE INTERSECTION OF MULTIPLE CLINICAL SPECIALTIES

NEPHROLOGY, METABOLISM, ENDOCRINOLOGY, DIABETOLOGY, PULMONARY HYPERTENSION, LIPIDOLOGY

CARDIO-NEUROLOGY,

CARDIO-ONCOLOGY, RARE DISEASES, GERIATRY, PEDIATRIC CARDIOLOGY AND OTHERS…

ONLY THINK-TANK MULTISTAKEHOLDER BRAINSTORMING, NON-COMPETITIVE CASE STUDIES.

1/13

BUILDING BRIDGES

1/11

bottom of page